Agenus Inc (AGEN) 6.08 $AGEN
Will Agenus (AGEN) Disappoint in Q1 Earning Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:30PM CDT
Agenus (AGEN) is expected to report first-quarter 2015 results on Apr 23.
AGEN: 6.08 (+0.21), BIIB: 423.57 (+1.46), INCY: 107.98 (-1.20), IMGN: 9.96 (+0.01)
Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 22, 7:11AM CDT
Biotechnology is rapidly giving rise to ground-breaking new medicines that are dramatically changing the outlook for devastating diseases such as hepatitis C, malaria, and, perhaps most astoundingly, cancer. This innovation boom has gone hand in hand...
AGEN: 6.08 (+0.21), ADXS: 22.18 (+0.10), PFE: 34.93 (+0.04), MRK: 57.69 (+0.03), AZN: 73.35 (+0.65), BMY: 66.60 (-0.21), FPRX: 24.07 (-0.85)
Will Agenus (AGEN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 6:28AM CDT
Will Agenus (AGEN) Continue to Surge Higher?
AGEN: 6.08 (+0.21)
Antigenics Up 75.6% Since SmarTrend Uptrend Call (AGEN)
Comtex SmarTrend(R) - Tue Apr 21, 9:47AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 75.65% as of today's recent price of $5.80.
AGEN: 6.08 (+0.21)
Agenus to Report First Quarter 2015 Financial Results on April 23, 2015; Conference Call to Follow
Business Wire - Mon Apr 20, 6:50AM CDT
Agenus Inc. (NASDAQ: AGEN) will release its first quarter 2015 financial results before the market opens on Thursday, April 23, 2015. Agenus executives will host a conference call at 11 a.m. Eastern Time the same day.
AGEN: 6.08 (+0.21)
3 Stocks That Could Double Your Money
George Budwell, The Motley Fool - Motley Fool - Sun Apr 19, 9:03AM CDT
If you're looking for a shot at doubling an investment, you'll want to take a look at the biotech industry. Biotech companies have been some of the best-performing stocks over the last couple of years thanks to the powerful confluence of numerous...
DVAX: 23.41 (-0.07), AGEN: 6.08 (+0.21), ACAD: 38.55 (-0.20)
Technical Coverage on Biotech Stocks -- Agenus, Raptor Pharma, KaloBios Pharma, Amicus Therapeutics, and Sarepta Therapeutics
PR Newswire - Fri Apr 17, 7:45AM CDT
Editor Note: For more information about this release, please scroll to bottom.
AGEN: 6.08 (+0.21), KBIO: 0.57 (-0.02), RPTP: 10.56 (-0.17), SRPT: 13.52 (+0.04), FOLD: 11.97 (-0.35)
Antigenics Shares Up 68.5% Since SmarTrend's Buy Recommendation (AGEN)
Comtex SmarTrend(R) - Tue Apr 14, 9:15AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 68.48% as of today's recent price of $5.56.
AGEN: 6.08 (+0.21)
Agenus buys Celexion's antibody assets
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 9:50AM CDT
AGEN: 6.08 (+0.21)
Agenus Acquires Celexion Assets and Expands Its Antibody Discovery Platform
Business Wire - Wed Apr 08, 6:00AM CDT
--Combination with Agenus' mammalian Retrocyte Display(TM) technology to result in a uniquely powerful antibody platform
AGEN: 6.08 (+0.21)
Antigenics Up 59.7% Since SmarTrend Uptrend Call (AGEN)
Comtex SmarTrend(R) - Mon Apr 06, 4:45PM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 59.70% as of today's recent price of $5.27.
AGEN: 6.08 (+0.21)
Don't Play With Propane - Cramer's Lightning Round (4/1/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Apr 02, 6:02AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, April 1. Bullish Calls: Insys Therapeutics (NASDAQ: INSY ): "Good company. Makes money, but be careful because Johnson & Johnson (NYSE: JNJ )...
MNK: 122.95 (-2.22), KMI: 44.07 (+0.46), KSS: 75.91 (+0.96), MCK: 231.27 (-0.02), UNH: 117.81 (-1.47), ALK: 64.31 (-0.62), AGEN: 6.08 (+0.21), URBN: 42.17 (+0.03), DDS: 136.44 (-0.34), SBUX: 48.33 (-0.04), JNJ: 100.43 (+0.13), HCA: 77.53 (-0.15), INSY: 62.10 (+0.76), DNKN: 47.72 (+0.21), AMAT: 22.31 (+0.02), FGP: 23.82 (+0.22), BIG: 47.15 (+0.11), KPTI: 32.24 (-0.60)
'Mad Money' Lightning Round: Kinder Morgan, HCA Are Winners
at The Street - Thu Apr 02, 5:00AM CDT
Cramer says to be careful on Insys Therapeutics, prefers Starbucks over Dunkin Brands and would buy Alaska Air.
KMI: 44.07 (+0.46), KSS: 75.91 (+0.96), MCK: 231.27 (-0.02), UNH: 117.81 (-1.47), ALK: 64.31 (-0.62), URBN: 42.17 (+0.03), SBUX: 48.33 (-0.04), AGEN: 6.08 (+0.21), DDS: 136.44 (-0.34), HCA: 77.53 (-0.15), DNKN: 47.72 (+0.21), INSY: 62.10 (+0.76), AMAT: 22.31 (+0.02), FGP: 23.82 (+0.22), BIG: 47.15 (+0.11), KPTI: 32.24 (-0.60)
Jim Cramer's 'Mad Money' Recap: Get Ready for a Rough Ride
at The Street - Wed Apr 01, 7:22PM CDT
Supply is the true enemy of the bull and there's a lot of new supply hitting the markets, Cramer says.
CXO: 123.60 (+0.33), KMI: 44.07 (+0.46), TSLA: 219.44 (+10.03), KSS: 75.91 (+0.96), GE: 26.91 (+0.29), EMES: 51.50 (+0.20), FRPT: 22.79 (-0.60), UTX: 116.96 (+0.01), UNH: 117.81 (-1.47), FCX: 20.57 (+0.34), BPT: 67.68 (+1.51), SDRL: 11.33 (+0.28), SLB: 92.16 (+0.87), SBUX: 48.33 (-0.04), DNKN: 47.72 (+0.21), INSY: 62.10 (+0.76), LNCO: 12.34 (+0.46), AMAT: 22.31 (+0.02), CRZO: 52.72 (+0.32), FGP: 23.82 (+0.22), AAPL: 128.62 (+1.71), SIRI: 3.94 (unch), ABT: 48.35 (+1.23), MCK: 231.27 (-0.02), BMY: 66.60 (-0.21), ALK: 64.31 (-0.62), ARP: 9.04 (-0.02), URBN: 42.17 (+0.03), DDS: 136.44 (-0.34), AGEN: 6.08 (+0.21), PM: 83.69 (-0.36), HCA: 77.53 (-0.15), RDS.A: 62.36 (-0.06), TXMD: 7.17 (+0.01), BIG: 47.15 (+0.11), GDDY: 24.77 (-0.01), KPTI: 32.24 (-0.60)
Why It's Not Too Late to Buy Agenus, Inc. Stock
George Budwell, The Motley Fool - Motley Fool - Tue Mar 31, 8:01AM CDT
Shares of clinical-stage biopharma Agenus have been on fire since the company acquired 4-Antibody in February 2014, allowing it to greatly expand its activities in the burgeoning field of immuno-oncology. Despite some recent weakness because of a...
AGEN: 6.08 (+0.21), PFE: 34.93 (+0.04), MRK: 57.69 (+0.03), INCY: 107.98 (-1.20), GSK: 46.57 (-0.67)
53.6% Return Seen to Date on SmarTrend Antigenics Call (AGEN)
Comtex SmarTrend(R) - Mon Mar 30, 11:09AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 53.64% as of today's recent price of $5.07.
AGEN: 6.08 (+0.21)
Antigenics Shares Up 59.1% Since SmarTrend's Buy Recommendation (AGEN)
Comtex SmarTrend(R) - Thu Mar 19, 9:20AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 3 months, Antigenics has returned 59.09% as of today's recent price of $5.25.
AGEN: 6.08 (+0.21)
Scanning Biotech Equities -- Agenus, Amicus Therapeutics, Peregrine Pharma, Vanda Pharma, and Acorda Therapeutics
PR Newswire - Thu Mar 12, 7:55AM CDT
Editor Note: For more information about this release, please scroll to bottom.
AGEN: 6.08 (+0.21), VNDA: 9.99 (-0.25), PPHM: 1.42 (-0.01), ACOR: 33.34 (-1.33), FOLD: 11.97 (-0.35)
Agenus' (AGEN) CEO Garo Armen on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 27, 6:21PM CST
AGEN: 6.08 (+0.21)
Will Agenus (AGEN) Disappoint in Q1 Earning Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:30PM CDT
Agenus (AGEN) is expected to report first-quarter 2015 results on Apr 23.
AGEN: 6.08 (+0.21), BIIB: 423.57 (+1.46), INCY: 107.98 (-1.20), IMGN: 9.96 (+0.01)
Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 22, 7:11AM CDT
Biotechnology is rapidly giving rise to ground-breaking new medicines that are dramatically changing the outlook for devastating diseases such as hepatitis C, malaria, and, perhaps most astoundingly, cancer. This innovation boom has gone hand in hand...
AGEN: 6.08 (+0.21), ADXS: 22.18 (+0.10), PFE: 34.93 (+0.04), MRK: 57.69 (+0.03), AZN: 73.35 (+0.65), BMY: 66.60 (-0.21), FPRX: 24.07 (-0.85)
Will Agenus (AGEN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 6:28AM CDT
Will Agenus (AGEN) Continue to Surge Higher?
AGEN: 6.08 (+0.21)
Antigenics Up 75.6% Since SmarTrend Uptrend Call (AGEN)
Comtex SmarTrend(R) - Tue Apr 21, 9:47AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 75.65% as of today's recent price of $5.80.
AGEN: 6.08 (+0.21)
Agenus to Report First Quarter 2015 Financial Results on April 23, 2015; Conference Call to Follow
Business Wire - Mon Apr 20, 6:50AM CDT
Agenus Inc. (NASDAQ: AGEN) will release its first quarter 2015 financial results before the market opens on Thursday, April 23, 2015. Agenus executives will host a conference call at 11 a.m. Eastern Time the same day.
AGEN: 6.08 (+0.21)
3 Stocks That Could Double Your Money
George Budwell, The Motley Fool - Motley Fool - Sun Apr 19, 9:03AM CDT
If you're looking for a shot at doubling an investment, you'll want to take a look at the biotech industry. Biotech companies have been some of the best-performing stocks over the last couple of years thanks to the powerful confluence of numerous...
DVAX: 23.41 (-0.07), AGEN: 6.08 (+0.21), ACAD: 38.55 (-0.20)
Technical Coverage on Biotech Stocks -- Agenus, Raptor Pharma, KaloBios Pharma, Amicus Therapeutics, and Sarepta Therapeutics
PR Newswire - Fri Apr 17, 7:45AM CDT
Editor Note: For more information about this release, please scroll to bottom.
AGEN: 6.08 (+0.21), KBIO: 0.57 (-0.02), RPTP: 10.56 (-0.17), SRPT: 13.52 (+0.04), FOLD: 11.97 (-0.35)
Antigenics Shares Up 68.5% Since SmarTrend's Buy Recommendation (AGEN)
Comtex SmarTrend(R) - Tue Apr 14, 9:15AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 68.48% as of today's recent price of $5.56.
AGEN: 6.08 (+0.21)
Agenus buys Celexion's antibody assets
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 9:50AM CDT
AGEN: 6.08 (+0.21)
Agenus Acquires Celexion Assets and Expands Its Antibody Discovery Platform
Business Wire - Wed Apr 08, 6:00AM CDT
--Combination with Agenus' mammalian Retrocyte Display(TM) technology to result in a uniquely powerful antibody platform
AGEN: 6.08 (+0.21)
Antigenics Up 59.7% Since SmarTrend Uptrend Call (AGEN)
Comtex SmarTrend(R) - Mon Apr 06, 4:45PM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 59.70% as of today's recent price of $5.27.
AGEN: 6.08 (+0.21)
Don't Play With Propane - Cramer's Lightning Round (4/1/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Apr 02, 6:02AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, April 1. Bullish Calls: Insys Therapeutics (NASDAQ: INSY ): "Good company. Makes money, but be careful because Johnson & Johnson (NYSE: JNJ )...
MNK: 122.95 (-2.22), KMI: 44.07 (+0.46), KSS: 75.91 (+0.96), MCK: 231.27 (-0.02), UNH: 117.81 (-1.47), ALK: 64.31 (-0.62), AGEN: 6.08 (+0.21), URBN: 42.17 (+0.03), DDS: 136.44 (-0.34), SBUX: 48.33 (-0.04), JNJ: 100.43 (+0.13), HCA: 77.53 (-0.15), INSY: 62.10 (+0.76), DNKN: 47.72 (+0.21), AMAT: 22.31 (+0.02), FGP: 23.82 (+0.22), BIG: 47.15 (+0.11), KPTI: 32.24 (-0.60)
'Mad Money' Lightning Round: Kinder Morgan, HCA Are Winners
at The Street - Thu Apr 02, 5:00AM CDT
Cramer says to be careful on Insys Therapeutics, prefers Starbucks over Dunkin Brands and would buy Alaska Air.
KMI: 44.07 (+0.46), KSS: 75.91 (+0.96), MCK: 231.27 (-0.02), UNH: 117.81 (-1.47), ALK: 64.31 (-0.62), URBN: 42.17 (+0.03), SBUX: 48.33 (-0.04), AGEN: 6.08 (+0.21), DDS: 136.44 (-0.34), HCA: 77.53 (-0.15), DNKN: 47.72 (+0.21), INSY: 62.10 (+0.76), AMAT: 22.31 (+0.02), FGP: 23.82 (+0.22), BIG: 47.15 (+0.11), KPTI: 32.24 (-0.60)
Jim Cramer's 'Mad Money' Recap: Get Ready for a Rough Ride
at The Street - Wed Apr 01, 7:22PM CDT
Supply is the true enemy of the bull and there's a lot of new supply hitting the markets, Cramer says.
CXO: 123.60 (+0.33), KMI: 44.07 (+0.46), TSLA: 219.44 (+10.03), KSS: 75.91 (+0.96), GE: 26.91 (+0.29), EMES: 51.50 (+0.20), FRPT: 22.79 (-0.60), UTX: 116.96 (+0.01), UNH: 117.81 (-1.47), FCX: 20.57 (+0.34), BPT: 67.68 (+1.51), SDRL: 11.33 (+0.28), SLB: 92.16 (+0.87), SBUX: 48.33 (-0.04), DNKN: 47.72 (+0.21), INSY: 62.10 (+0.76), LNCO: 12.34 (+0.46), AMAT: 22.31 (+0.02), CRZO: 52.72 (+0.32), FGP: 23.82 (+0.22), AAPL: 128.62 (+1.71), SIRI: 3.94 (unch), ABT: 48.35 (+1.23), MCK: 231.27 (-0.02), BMY: 66.60 (-0.21), ALK: 64.31 (-0.62), ARP: 9.04 (-0.02), URBN: 42.17 (+0.03), DDS: 136.44 (-0.34), AGEN: 6.08 (+0.21), PM: 83.69 (-0.36), HCA: 77.53 (-0.15), RDS.A: 62.36 (-0.06), TXMD: 7.17 (+0.01), BIG: 47.15 (+0.11), GDDY: 24.77 (-0.01), KPTI: 32.24 (-0.60)
Why It's Not Too Late to Buy Agenus, Inc. Stock
George Budwell, The Motley Fool - Motley Fool - Tue Mar 31, 8:01AM CDT
Shares of clinical-stage biopharma Agenus have been on fire since the company acquired 4-Antibody in February 2014, allowing it to greatly expand its activities in the burgeoning field of immuno-oncology. Despite some recent weakness because of a...
AGEN: 6.08 (+0.21), PFE: 34.93 (+0.04), MRK: 57.69 (+0.03), INCY: 107.98 (-1.20), GSK: 46.57 (-0.67)
53.6% Return Seen to Date on SmarTrend Antigenics Call (AGEN)
Comtex SmarTrend(R) - Mon Mar 30, 11:09AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 4 months, Antigenics has returned 53.64% as of today's recent price of $5.07.
AGEN: 6.08 (+0.21)
Antigenics Shares Up 59.1% Since SmarTrend's Buy Recommendation (AGEN)
Comtex SmarTrend(R) - Thu Mar 19, 9:20AM CDT
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 3 months, Antigenics has returned 59.09% as of today's recent price of $5.25.
AGEN: 6.08 (+0.21)
Scanning Biotech Equities -- Agenus, Amicus Therapeutics, Peregrine Pharma, Vanda Pharma, and Acorda Therapeutics
PR Newswire - Thu Mar 12, 7:55AM CDT
Editor Note: For more information about this release, please scroll to bottom.
AGEN: 6.08 (+0.21), VNDA: 9.99 (-0.25), PPHM: 1.42 (-0.01), ACOR: 33.34 (-1.33), FOLD: 11.97 (-0.35)
Agenus' (AGEN) CEO Garo Armen on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 27, 6:21PM CST
AGEN: 6.08 (+0.21)
